Pete Buzy

Peter Buzy is an accomplished professional with extensive experience in the healthcare and biotechnology sectors. Currently serving on the Board of Directors for Pyramid Labs, AeroSafe Global, LumaCyte, and Deka Biosciences, Inc., as well as holding the position of Advisory Partner at NewSpring and Advisory Board Member at Spring Capital Partners, Peter Buzy brings significant leadership expertise. Previous roles include Chairman and President of Gene Therapy at Catalent Pharma Solutions and President & CEO of Paragon Bioservices, Inc. Peter Buzy has been involved with the Tech Council of Maryland and has contributed as a judge for the EY Entrepreneur of the Year 2015. Peter Buzy holds a Bachelor of Science in Accounting from Salisbury State University.